Use of Genetic Markers in Multiple Myeloma

  H&O  In what ways is multiple myeloma a genetically heterogeneous disease? RF  In an editorial written several years ago, I referred to this disease as […]

Myeloma Bone Disease: Pathogenesis and Treatment

  Abstract: Bone involvement manifesting as osteolytic bone disease (OBD) or osteopenia is one of the defining features of multiple myeloma (MM). Osteolytic lesions develop in […]

Monoclonal Antibodies in Multiple Myeloma: Data From the 2015 ASH Meeting

H&O What are the most important principles in the management of multiple myeloma? SL In the past few years, treatment options for myeloma have increased and […]